Hallucinogenic Drug Helps Patients with Advanced Cancer
NYU Langone study finds the hallucinogenic drug psilocybin, when combined with counseling, relieves depression and anxiety in cancer patients.
Psychedelic Drug Therapy May Help Treat Alcohol Addiction
NYU Langone study shows that 2 doses of psilocybin combined with psychotherapy reduces alcohol consumption by 83 percent among heavy drinkers.
Psychedelic Drug Benefits Persist in People with Cancer
NYU Langone study finds a psychedelic drug improved emotional distress in people with cancer for nearly five years after treatment.
Novel Therapeutic Agents for Hard-to-Treat Mental Conditions
NYU Langone’s Dr. Michael P. Bogenschutz, Dr. Stephen Ross, and colleagues explore therapeutic agents such as psilocybin, cannabidiol, and MDMA.
Podcast: Rethinking the Role of Psychedelics in Medicine
NYU Langone psychiatrist Dr. Stephen Ross sees potential for psychedelic drugs to treat anxiety, depression, and other mental health disorders.
Podcast: How the Pandemic Has Changed These Doctors
Three NYU Langone doctors discuss the impact of the COVID-19 pandemic on healthcare and new advances in their fields.
NYU Langone Health in the News — August 15, 2023
At NYU Langone, our experts are frequently featured in various media outlets to share their skills and knowledge. See the stories from August 15, 2023.
NYU Langone Health in the News—June 2, 2023
At NYU Langone, our experts are frequently featured in various media outlets to share their skills and knowledge. See the stories from June 2, 2023.
NYU Langone Health in the News — July 14, 2023
At NYU Langone, our experts are frequently featured in various media outlets to share their skills and knowledge. See the stories from July 14, 2023.
NYU Langone Establishes New Center for Psychedelic Medicine
NYU Langone Health opens a comprehensive Center for Psychedelic Medicine, building on its leadership position in this resurging field.
